Literature DB >> 31803916

Vascular responses to coronary calcification following implantation of newer-generation drug-eluting stents in humans: impact on healing.

Sho Torii1, Hiroyuki Jinnouchi1, Atsushi Sakamoto1, Hiroyoshi Mori1, Joohyung Park1, Falone C Amoa1, Mariem Sawan2, Yu Sato1, Anne Cornelissen1, Salome H Kuntz1, Matthew Kutyna1, Ka Hyun Paek1, Raquel Fernandez1, Ryan Braumann1, Eric K Mont3, Dipti Surve1, Maria E Romero1, Frank D Kolodgie1, Renu Virmani1, Aloke V Finn1,2.   

Abstract

AIMS: Vascular calcification is routinely encountered in percutaneous coronary intervention (PCI) and severe coronary calcification is a known predictor of in-stent restenosis and stent thrombosis. However, the histopathologic mechanisms behind such events have not been systematically described. METHODS AND
RESULTS: From our registry of 1211 stents, a total of 134 newer-generation drug-eluting stents (DES) (Xience, Resolute-Integrity, PROMUS-Element, and Synergy) with duration of implant ≥30 days were histologically analysed. The extent of calcification of the stented lesions was evaluated radiographically and divided into severe (SC, n = 46) and non-severely calcified lesions (NC, n = 88). The percent-uncovered struts per section {SC vs. NC; median 2.4 [interquartile range (IQR) 0.0-19.0] % vs. 0.0 (IQR 0.0-4.6) %, P = 0.02} and the presence of severe medial tears (MTs) (59% vs. 44%, respectively, P = 0.03) were greater in SC than NC. In addition, SC had a higher prevalence of ≥3 consecutive struts lying directly in contact with surface calcified area (3SC) (52% vs. 8%, respectively, P < 0.0001). Multivariate analysis demonstrated that sections with duration of implantation ≤6 months [odds ratio (OR): 7.7, P < 0.0001], 3SC (OR: 6.5, P < 0.0001), strut malapposition (OR: 5.0, P < 0.0001), and lack of MTs (OR: 2.5, P = 0.0005) were independent predictors of uncovered struts. Prevalence of neoatherosclerosis was significantly lower in SC than that of NC (24% vs. 44%, P = 0.02).
CONCLUSION: Severe calcification, especially surface calcified area is an independent predictor of uncovered struts and delayed healing after newer-generation DES implantation. These data expand of knowledge of the vascular responses of stenting of calcified arteries and suggests further understand of how best to deal with calcification in patients undergoing PCI. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Uncovered strut; Coronary artery calcification; Drug-eluting stents; Dual antiplatelet therapy; Percutaneous coronary intervention; Stent thrombosis

Mesh:

Year:  2020        PMID: 31803916      PMCID: PMC7828465          DOI: 10.1093/eurheartj/ehz850

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  35 in total

1.  Favorable early vessel healing after everolimus-eluting stent implantation: 3-, 6-, and 12-month follow-up of optical coherence tomography.

Authors:  Akihide Konishi; Masamichi Iwasaki; Toshiro Shinke; Hiromasa Otake; Tomofumi Takaya; Tsuyoshi Osue; Ryo Nishio; Hiroto Kinutani; Masaru Kuroda; Hachidai Takahashi; Daisuke Terashita; Junya Shite; Ken-Ichi Hirata
Journal:  J Cardiol       Date:  2018-07-03       Impact factor: 3.159

2.  Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.

Authors:  Tullio Palmerini; Umberto Benedetto; Giuseppe Biondi-Zoccai; Diego Della Riva; Letizia Bacchi-Reggiani; Pieter C Smits; Georgios J Vlachojannis; Lisette Okkels Jensen; Evald H Christiansen; Klára Berencsi; Marco Valgimigli; Carlotta Orlandi; Mario Petrou; Claudio Rapezzi; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

3.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Marco Valgimigli; Héctor Bueno; Robert A Byrne; Jean-Philippe Collet; Francesco Costa; Anders Jeppsson; Peter Jüni; Adnan Kastrati; Philippe Kolh; Laura Mauri; Gilles Montalescot; Franz-Josef Neumann; Mate Petricevic; Marco Roffi; Philippe Gabriel Steg; Stephan Windecker; Jose Luis Zamorano; Glenn N Levine
Journal:  Eur Heart J       Date:  2018-01-14       Impact factor: 29.983

4.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Authors:  Juhani Knuuti; William Wijns; Antti Saraste; Davide Capodanno; Emanuele Barbato; Christian Funck-Brentano; Eva Prescott; Robert F Storey; Christi Deaton; Thomas Cuisset; Stefan Agewall; Kenneth Dickstein; Thor Edvardsen; Javier Escaned; Bernard J Gersh; Pavel Svitil; Martine Gilard; David Hasdai; Robert Hatala; Felix Mahfoud; Josep Masip; Claudio Muneretto; Marco Valgimigli; Stephan Achenbach; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

5.  Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents.

Authors:  Giulio Guagliumi; Kunihiro Shimamura; Vasile Sirbu; Roberto Garbo; Giacomo Boccuzzi; Angelina Vassileva; Orazio Valsecchi; Luigi Fiocca; Paolo Canova; Francesco Colombo; Gabriel Tensol Rodriguez Pereira; Daisuke Nakamura; Guilherme F Attizzani; Alberto Cereda; Keisuke Satogami; Leonardo De Luca; Francesco Saia; Davide Capodanno
Journal:  Eur Heart J       Date:  2018-07-07       Impact factor: 29.983

6.  Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.

Authors:  Aloke V Finn; Michael Joner; Gaku Nakazawa; Frank Kolodgie; John Newell; Mike C John; Herman K Gold; Renu Virmani
Journal:  Circulation       Date:  2007-04-16       Impact factor: 29.690

7.  Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.

Authors:  Gaku Nakazawa; Aloke V Finn; Marc Vorpahl; Elena Ladich; Robert Kutys; Isidora Balazs; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

8.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský
Journal:  Eur Heart J       Date:  2018-01-07       Impact factor: 29.983

9.  Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.

Authors:  Gaku Nakazawa; Aloke V Finn; Michael Joner; Elena Ladich; Robert Kutys; Erik K Mont; Herman K Gold; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

10.  Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).

Authors:  Tom Adriaenssens; Michael Joner; Thea C Godschalk; Nikesh Malik; Fernando Alfonso; Erion Xhepa; Dries De Cock; Kenichi Komukai; Tomohisa Tada; Javier Cuesta; Vasile Sirbu; Laurent J Feldman; Franz-Josef Neumann; Alison H Goodall; Ton Heestermans; Ian Buysschaert; Ota Hlinomaz; Ann Belmans; Walter Desmet; Jurrien M Ten Berg; Anthony H Gershlick; Steffen Massberg; Adnan Kastrati; Giulio Guagliumi; Robert A Byrne
Journal:  Circulation       Date:  2017-07-18       Impact factor: 29.690

View more
  4 in total

1.  Finite element analysis in clinical patients with atherosclerosis.

Authors:  Christopher Noble; Kent D Carlson; Erica Neumann; Bradley Lewis; Dan Dragomir-Daescu; Amir Lerman; Ahmet Erdemir; Melissa D Young
Journal:  J Mech Behav Biomed Mater       Date:  2021-10-30

2.  Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach.

Authors:  Jingyuan Hou; Qiaoting Deng; Sudong Liu; Xiaohong Qiu; Xunwei Deng; Wei Zhong; Zhixiong Zhong
Journal:  Front Cardiovasc Med       Date:  2022-02-21

3.  Cause of Stent Failure in Patients on Hemodialysis.

Authors:  Yu Sato; Aloke V Finn; Renu Virmani
Journal:  J Am Heart Assoc       Date:  2020-09-23       Impact factor: 5.501

4.  Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model.

Authors:  Sho Torii; Tadashi Yamamoto; Norihito Nakamura; Takeshi Ijichi; Ayako Yoshikawa; Yusuke Ito; Atsuhiro Sugidachi; Yuji Ikari; Gaku Nakazawa
Journal:  Circ Rep       Date:  2021-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.